FULL Product Information (PI) and Consumer Medicines Information (CMI) for Pfizer's Paxlovid (nirmatrelvir and ritonavir) and MSD's Lagevrio (molnupiravir) oral COVID-19 treatments can now be accessed via MIMS Online, the eMIMS Cloud and the mims.com.au website.
The two medications received provisional approval from the Therapeutic Goods Administration (TGA) for the treatment of COVID-19 in adults at increased risk of hospitalisation last month (PD 20 Jan).
The drugs will be included and searchable in MIMS from 01 Mar.
The above article was sent to subscribers in Pharmacy Daily's issue from 15 Feb 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Feb 22
